Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations

Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations

Introduction: Multiple Sclerosis (MS) is the most common immune-mediated chronic neurodegenerative disease of the central nervous system (CNS) affecting young people. This is due to the permanent disability, cognitive impairment, and the enormous detrimental impact MS can exert on a patient’s health...

Full description

Bibliographic Details
Main Authors: Tamás Biernacki, Zsófia Kokas, Dániel Sandi, Judit Füvesi, Zsanett Fricska-Nagy, Péter Faragó, Tamás Zsigmond Kincses, Péter Klivényi, Krisztina Bencsik, László Vécsei
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
biomarker
diagnostic
prognostic
blood
cerebrospinal fluid
multiple sclerosis
Online Access:https://www.mdpi.com/1422-0067/23/6/3383

Internet

https://www.mdpi.com/1422-0067/23/6/3383

Similar Items